HB 800: Active Pharmaceutical Ingredient Manufacturing Grant Fund; established.

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Active Pharmaceutical Ingredient Manufacturing Grant Fund. Establishes the Active Pharmaceutical Ingredient Manufacturing Grant Fund to provide grant installment awards between July 1, 2026, and July 1, 2045, in an amount not to exceed $15 million per fiscal year and in an aggregate amount not to exceed $130 million, to a qualified company that (i) engages in the manufacture of pharmaceutical substances, (ii) executes a memorandum of understanding with the Commonwealth, and (iii) is expected to make a capital investment of at least $2,148,793,019 and create and maintain at least 468 new full-time jobs. This bill is identical to SB 404.

Sponsors

Sponsors by party (alphabetical): Democratic 2

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

1. April 13, 2026Approved by Governor-Chapter 804 (effective 7/1/2026)
2. March 10, 2026Governor's Action Deadline 11:59 p.m., April 13, 2026
3. March 10, 2026Enrolled Bill communicated to Governor on March 10, 2026
4. February 23, 2026Signed by President
5. February 23, 2026Signed by Speaker
6. February 23, 2026Fiscal Impact Statement from Department of Planning and Budget (HB800)
7. February 23, 2026Bill text as passed House and Senate (HB800ER)
8. February 23, 2026Enrolled
9. February 19, 2026Passed Senate Block Vote (39-Y 0-N 0-A)
10. February 19, 2026Read third time
11. February 18, 2026Passed by for the day
12. February 18, 2026Constitutional reading dispensed Block Vote (on 2nd reading) (38-Y 0-N 0-A)

Showing 12 most recent of 27 actions. Full history